Goodrx Holdings Inc (GDRX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Goodrx Holdings Inc stock (GDRX) is currently trading at $2.06. Goodrx Holdings Inc PE ratio is 22.56. Goodrx Holdings Inc PS ratio (Price-to-Sales) is 0.87. Analyst consensus price target for GDRX is $2.81. WallStSmart rates GDRX as Sell.
- GDRX PE ratio analysis and historical PE chart
- GDRX PS ratio (Price-to-Sales) history and trend
- GDRX intrinsic value — DCF, Graham Number, EPV models
- GDRX stock price prediction 2025 2026 2027 2028 2029 2030
- GDRX fair value vs current price
- GDRX insider transactions and insider buying
- Is GDRX undervalued or overvalued?
- Goodrx Holdings Inc financial analysis — revenue, earnings, cash flow
- GDRX Piotroski F-Score and Altman Z-Score
- GDRX analyst price target and Smart Rating
Goodrx Holdings Inc
📊 No data available
Try selecting a different time range
GDRX Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Goodrx Holdings Inc (GDRX)
GDRX trades 266% above its Graham fair value of $0.61, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Goodrx Holdings Inc (GDRX) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around return on equity and revenue growth. Mixed signals suggest waiting for clearer direction before acting.
Goodrx Holdings Inc (GDRX) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading at 1.13x book value, attractively priced
57.75% held by institutions, strong professional interest
Supporting Valuation Data
Goodrx Holdings Inc (GDRX) Areas to Watch (6)
Revenue declining -1.90%, a shrinking business
Earnings declining -9.70%, profits shrinking
Very low returns on shareholder equity
Very thin margins, barely profitable
Small-cap company with higher risk but more growth potential
Decent operational efficiency, solid but not exceptional
Goodrx Holdings Inc (GDRX) Detailed Analysis Report
Overall Assessment
This company scores 41/100 in our Smart Analysis, earning a D grade. Out of 9 metrics analyzed, 3 register as strengths (avg 8.7/10) while 6 fall into concern territory (avg 2.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.87), Price/Book (1.13) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Return on Equity. Growth concerns include Revenue Growth at -1.90%, EPS Growth at -9.70%, which may limit upside. Profitability pressure is visible in Return on Equity at 4.54%, Operating Margin at 19.00%, Profit Margin at 3.82%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 4.54% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -1.90% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Revenue Growth and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
GDRX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
GDRX's Price-to-Sales ratio of 0.87x sits near its historical average of 0.93x (14th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 15% below its historical high of 1.03x set in Mar 2026, and 8% above its historical low of 0.81x in Feb 2026.
Compare GDRX with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Goodrx Holdings Inc (GDRX) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
Goodrx Holdings Inc faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 797M with 190% decline year-over-year. Profit margins are strong at 382.0%, reflecting pricing power and operational efficiency.
Key Findings
ROE of 454.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Profit margin of 382.0% and operating margin of 19.0% demonstrate strong pricing power and operational efficiency.
Revenue contracted 190% YoY. Worth determining whether this is cyclical or structural.
What to Watch Next
Volatility is elevated with a beta of 1.56, so expect amplified moves relative to the broader market.
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Goodrx Holdings Inc.
Bottom Line
Goodrx Holdings Inc faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Goodrx Holdings Inc(GDRX)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
GoodRx Holdings, Inc. provides information and tools that allow consumers to compare prices and save when buying prescription drugs in the United States. The company is headquartered in Santa Monica, California.